Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M

Marc Aragó, Juan Moreno-Felici, Sonia Abás, Sergio Rodríguez-Arévalo, Petra Hyroššová, Agnes Figueras, Francesc Viñals, Belén Pérez, Maria I. Loza, Jose Brea, Pedro Latorre, Jose A. Carrodeguas, Pablo M. García-Rovés, Carlos Galdeano, Tiziana Ginex, Francisco J. Luque, Carmen Escolano, Jose C. Perales*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M'. Together they form a unique fingerprint.

Medicine & Life Sciences